Cardiome Pharma Sets New 1-Year High at $5.35 (CRME)
Cardiome Pharma (NASDAQ:CRME)’s share price reached a new 52-week high on Monday, American Banking and Market News reports. The company traded as high as $5.35 and last traded at $4.97, with a volume of 976,720 shares traded. The stock had previously closed at $4.10.
Separately, analysts at EuroPacific Canada initiated coverage on shares of Cardiome Pharma in a research note to investors on Thursday, July 25th. They set a “neutral” rating on the stock.
Cardiome Pharma has a 1-year low of $1.20 and a 1-year high of $4.14. The stock’s 50-day moving average is $2.65 and its 200-day moving average is $2.16. The company has a market cap of $62.8 million and a P/E ratio of 5.17.
Cardiome Pharma (NASDAQ:CRME) last posted its quarterly earnings results on Friday, August 2nd. The company reported ($0.22) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.19) by $0.03. During the same quarter in the prior year, the company posted ($0.45) earnings per share. On average, analysts predict that Cardiome Pharma will post $0.84 earnings per share for the current fiscal year.
Cardiome Pharma Corp. (NASDAQ:CRME) is a life sciences company focused on developing drugs to treat or prevent cardiovascular diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.